Skip to main content

Table 2 Predicting clinical metabolic syndrome variates from homocysteine, both unadjusted, and adjusted with sex and age

From: Type II diabetes mellitus and hyperhomocysteinemia: a complex interaction

 

Homocysteine ≥ 10

Homocysteine ≥ 10 (adjusted)

Homocysteine ≥ 15

Homocysteine ≥ 15 (adjusted)

Age ≥ 60

1.405

(1.17–1.69)

0.000294

 

1.504

(1.28–1.77)

8.81 × 10−7

 

Sex = male

2.074

(1.71–2.50)

2.98 × 10−14

 

1.586

(1.33–1.90)

3.23 × 10−7

–

DxHL

0.844

(0.70–1.01)

0.0706

0.873

(0.72–1.05)

0.154

0.816

(0.69–0.96)

0.0138

0.833

(0.71–0.98)

0.0286

HDL ≤ 40 (men), 50 (women)

0.952

(0.78–1.16)

0.628

1.014

(0.70–1.24)

0.890

1.085

(0.91–1.29)

0.356

1.151

(0.97–1.37)

0.115

Tg ≥ 200

0.977

(0.80–1.20)

0.826

0.968

(0.79–1.20)

0.764

0.923

(0.77–1.11)

0.390

0.937

(0.78–1.13)

0.491

DxT2DM

0.710

(0.59–0.86)

0.000521

0.698

(0.57–0.85)

0.000368

0.879

(0.74–1.05)

0.151

0.862

(0.72–1.03)

0.103

DxHTN

1.244

(1.03–1.50)

0.0212

1.301

(1.07–1.58)

0.00795

1.468

(1.24–1.74)

6.72 × 10−6

1.479

(1.24–1.76)

9.91 × 10−6

BMI ≥ 30

0.906

(0.75–1.10)

0.310

0.995

(0.82–1.21)

0.957

1.027

(0.87–1.21)

0.755

1.081

(0.91–1.28)

0.373

  1. Each block reports OR (95% CI), and p value